Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Conmed (CNMD) Net Cash Flow (2016 - 2026)

Conmed filings provide 17 years of Net Cash Flow readings, the most recent being -$5.0 million for Q1 2026.

On a quarterly basis, Net Cash Flow fell 148.72% to -$5.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.3 million, a 141.97% decrease, with the full-year FY2025 number at $13.9 million, up 382.42% from a year prior.
Net Cash Flow hit -$5.0 million in Q1 2026 for Conmed, down from $1.9 million in the prior quarter.
In the past five years, Net Cash Flow ranged from a high of $29.6 million in Q2 2022 to a low of -$18.5 million in Q3 2022.
Median Net Cash Flow over the past 5 years was $1.4 million (2023), compared with a mean of $914352.9.
The widest YoY moves for Net Cash Flow: up 466.12% in 2024, down 421.96% in 2024.
Conmed's Net Cash Flow stood at -$6.4 million in 2022, then dropped by 12.89% to -$7.2 million in 2023, then crashed by 62.91% to -$11.8 million in 2024, then soared by 115.75% to $1.9 million in 2025, then tumbled by 368.23% to -$5.0 million in 2026.
The last three reported values for Net Cash Flow were -$5.0 million (Q1 2026), $1.9 million (Q4 2025), and $5.0 million (Q3 2025) per Business Quant data.